Schedule 13G ownership disclosure

SUTRO BIOPHARMA INC

Common Stock · CUSIP: 869367102

Event date: 2025-06-30

Filing-level shares
4,115,250
Percent of class
4.87%
  • The Vanguard Group

    Shares: 4,115,250 · Class: 4.87%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-001053
Form type
SCHEDULE 13G/A
Filer
SUTRO BIOPHARMA, INC.
CIK
CIK 1382101
Filed
Jul 29, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub